EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

C-terminal TMEM106B fragments in human brain correlate with disease-associated TMEM106B haplotypes

Cristina T Vicente, Jolien Perneel, Sarah Wynants, Bavo Heeman, Marleen Van den Broeck, Matt Baker, Simon Cheung, Júlia Faura, Ian R A Mackenzie, Rosa Rademakers

Brain · 03.10.2023 · 146 (10) · 4055-4064

DOI: 10.1093/brain/awad133 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, online erschienen am 26.04.2023. Verfasst von Cristina T Vicente und 9 weiteren Autor:innen. Beteiligte Einrichtung: VIB Center for Molecular Neurology, University of Antwerp, 2610, Antwerp, Belgium. Hauptthemen laut MEDLINE: Frontotemporal Dementia, Frontotemporal Lobar Degeneration. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS, NINDS NIH HHS, University of Antwerp Research Funds.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transmembrane protein 106B (TMEM106B) is a tightly regulated glycoprotein predominantly localized to endosomes and lysosomes. Genetic studies have implicated TMEM106B haplotypes in the development of multiple neurodegenerative diseases with the strongest effect in frontotemporal lobar degeneration with TDP-43 pathology (FTLD-TDP), especially in progranulin (GRN) mutation carriers. Recently, cryo-electron microscopy studies showed that a C-terminal fragment (CTF) of TMEM106B (amino acid residues 120–254) forms amyloid fibrils in the brain of patients with FTLD-TDP, but also in brains with other neurodegenerative conditions and normal ageing brain. The functional implication of these fibrils and their relationship to the disease-associated TMEM106B haplotype remain unknown. We performed immunoblotting using a newly developed antibody to detect TMEM106B CTFs in the sarkosyl-insoluble fraction of post-mortem human brain tissue from patients with different proteinopathies (n = 64) as well as neuropathologically normal individuals (n = 10) and correlated the results with age and TMEM106B haplotype. We further compared the immunoblot results with immunohistochemical analyses performed in the same study population. Immunoblot analysis showed the expected ∼30 kDa band in the sarkosyl-insoluble fraction of frontal cortex tissue in at least some individuals with each of the conditions evaluated. Most patients with GRN mutations showed an intense band representing TMEM106B CTF, whereas in most neurologically normal individuals it was absent or much weaker. In the overall cohort, the presence of TMEM106B CTFs correlated strongly with both age (rs = 0.539, P < 0.001) and the presence of the TMEM106B risk haplotype (rs = 0.469, P < 0.001). Although there was a strong overall correlation between the results of immunoblot and immunohistochemistry (rs = 0.662, P < 0.001), 27 cases (37%) were found to have higher amounts of TMEM106B CTFs detected by immunohistochemistry, including most of the older individuals who were neuropathologically normal and individuals who carried two protective TMEM106B haplotypes. Our findings suggest that the formation of sarkosyl-insoluble TMEM106B CTFs is an age-related feature which is modified by TMEM106B haplotype, potentially underlying its disease-modifying effect. The discrepancies between immunoblot and immunohistochemistry in detecting TMEM106B pathology suggests the existence of multiple species of TMEM106B CTFs with possible biological relevance and disease implications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Frontotemporal DementiaFrontotemporal Lobar DegenerationHumansHaplotypesCryoelectron MicroscopyMembrane ProteinsNerve Tissue ProteinsBrain

Stichwörter der Autor:innen

TMEM106Bfibrilshaplotypeneurodegenerationprogranulin

Substanzen

Membrane ProteinsNerve Tissue ProteinsTMEM106B protein, human

Autor:innen und Institutionen

  • VIB Center for Molecular Neurology, University of Antwerp, 2610, Antwerp, Belgium.
  • Department of Biomedical Sciences, University of Antwerp, 2610, Antwerp, Belgium.
  • Department of Neuroscience, Mayo Clinic, Jacksonville, FL 32233, USA.
  • Department of Pathology, Vancouver Coastal Health, Vancouver, BC V5Z1M9, Canada.
  • Department of Pathology, University of British Columbia, Vancouver, BC V6T 1Z7, Canada.

Förderung

  • NIA NIH HHS
  • NINDS NIH HHS
  • University of Antwerp Research Funds
  • Vlaams Instituut voor Biotechnologie
  • National Institutes of Health
  • Canadian Institutes of Health Research
  • Research Foundation
  • Holloway Postdoctoral fellowship

Zitieren

APA

T Vicente, C., Perneel, J., Wynants, S., Heeman, B., Van den Broeck, M., Baker, M., Cheung, S., Faura, J., Mackenzie, I. R. A., & Rademakers, R. (2023). C-terminal TMEM106B fragments in human brain correlate with disease-associated TMEM106B haplotypes. Brain, 146(10), 4055-4064. https://doi.org/10.1093/brain/awad133

Vancouver

T Vicente C, Perneel J, Wynants S, Heeman B, Van den Broeck M, Baker M, et al. C-terminal TMEM106B fragments in human brain correlate with disease-associated TMEM106B haplotypes. Brain. 2023;146(10):4055-4064. doi:10.1093/brain/awad133

BibTeX
@article{TVicente2023,
  author = {T Vicente, Cristina and Perneel, Jolien and Wynants, Sarah and Heeman, Bavo and Van den Broeck, Marleen and Baker, Matt and Cheung, Simon and Faura, Júlia and Mackenzie, Ian R A and Rademakers, Rosa},
  title = {C-terminal TMEM106B fragments in human brain correlate with disease-associated TMEM106B haplotypes},
  journal = {Brain},
  year = {2023},
  volume = {146},
  number = {10},
  pages = {4055--4064},
  doi = {10.1093/brain/awad133}
}
Kostenlos starten →